NCT06369480View on ClinicalTrials.gov

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Cholangiocarcinoma
Interventions
PROCEDURE

Resection/Ablation of tumor

Curative treatment

PROCEDURE

Palliative chemotherapy

Chemotherapeutic medications

PROCEDURE

Neoadjuvant chemotherapy

Chemotherapeutic medications after surgery

PROCEDURE

Stereotatic radiotherapy

Radiotherapy

PROCEDURE

Best supportive care

Symptomatic treatment, non-curative treatment

Trial Locations (1)

2100

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER